Abstract Background Mycoplasma genitalium is an emerging sexually transmitted pathogen. M. genitalium is often asymptomatic but can cause urethritis, is associated with cervicitis and pelvic inflammatory disease, and possibly infertility and premature labor. Although multiplex sexually transmitted infection (STI) testing platforms that include M. genitalium are available, screening for asymptomatic infection is not recommended as its potential clinical impact is unknown. Leveraging the STD Clini